In breast and colon cancers, Dlx-2 expression higher in tumor tissues than in matched non-tumorigenic tissues and stromal cells around cancer cells, i.e., fibroblasts and lymphocytes (Figure 3A-F). Here, DLX2 is linked to cancer.